• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session

    9/22/22 12:26:59 PM ET
    $AGRI
    $ALBO
    $AVCT
    $BCAN
    Metal Fabrications
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AGRI alert in real time by email

     

    Gainers

    • Spero Therapeutics, Inc. (NASDAQ:SPRO) rose 150% to $2.0508 after the company announced it has entered into an exclusive license agreement with GSK for Spero's late-stage antibiotic asset, tebipenem HBr. Spero Therapeutics will receive $66 million upfront, with potential for future milestone payments, and tiered royalties.
    • HeartBeam, Inc. (NASDAQ:BEAT) shares gained 34% to $2.12 after dropping 16% on Wednesday. Heartbeam recently announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO.
    • ShiftPixy, Inc. (NASDAQ:PIXY) shares jumped 32.4% to $18.09. ShiftPixy, on Wednesday, announced pricing of $5 million private placement.
    • Inventiva S.A. (NASDAQ:IVA) gained 23.7% to $4.7250 after the company reported its 2022 first-half financial results and provided a corporate update.
    • Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) rose 22.7% to $1.6204. Sonnet BioTherapeutics recently announced progress in Phase 1 dose-escalation trials of SON-1010.
    • Talkspace, Inc. (NASDAQ:TALK) gained 18% to $0.9902.
    • Siyata Mobile Inc. (NASDAQ:SYTA) jumped 13.1% to $0.4275 after the company announced that it has received a purchase order from a federal government contractor who will provide Uniden cellular booster kits and accessories to the U.S. Navy.
    • Albireo Pharma, Inc. (NASDAQ:ALBO) gained 13% to $19.61. Albireo announced $115M royalty monetization agreement with Sagard.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) rose 11.9% to $0.2412.
    • Cosmos Holdings Inc. (NASDAQ:COSM) jumped 10.9% to $0.26 after Virax Biolabs announced that it has entered into a distribution agreement to market Monkeypox Virus Real-Time PCR Detection Kits with Cosmos.
    • Cassava Sciences, Inc. (NASDAQ:SAVA) gained 10.7% to $41.67.
    • Connexa Sports Technologies Inc. (NASDAQ:CNXA) gained 10.6% to $0.52.
    • Amprius Technologies, Inc. (NASDAQ:AMPX) jumped 10% to $10.43.
    • Zenvia Inc. (NASDAQ:ZENV) gained 9.6% to $1.60.
    • Virax Biolabs Group Limited (NASDAQ:VRAX) shares gained 9.4% to $3.3250 after the company announced it has entered into a distribution agreement to market Monkeypox Virus Real-Time PCR Detection Kits with Cosmos Holdings.
    • United Maritime Corporation (NASDAQ:USEA) gained 9.2% to $1.66. United completed stock buyback of $3 million and initiated additional $3 million stock buyback plan.
    • Virtu Financial, Inc. (NASDAQ:VIRT) gained 8.7% to $23.27 after it was reported the SEC is poised to let Wall Street keep payment-for-order-flow deals.
    • Trip.com Group Limited (NASDAQ:TCOM) jumped 7.7% to $26.32 after the company reported Q2 financial results.
    • Li Auto Inc. (NASDAQ:LI) gained 7.6% to $24.84 after the company announced it will host a launch event to unveil the Li L8 on Friday, September 30, 2022, ahead of schedule.
    • Eve Holding, Inc. (NYSE:EVEX) gained 7.5% to $13.31.
    • Deutsche Bank Aktiengesellschaft (NYSE:DB) rose 3.7% to $8.92. Deutsche Bank said its New York Branch, Deutsche Bank New York, and its affiliate Deutsche Bank Trust Company Americas have raised their prime lending from 5.50% to 6.25%.

     

     

    Losers

    • Pintec Technology Holdings Limited (NASDAQ:PT) dipped 32.2% to $0.3999.
    • Top Ships Inc. (NASDAQ:TOPS) dropped 23% to $0.1646 after the company announced a 1-for-20 reverse stock split.
    • BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) shares fell 21.5% to $3.4604. The company on Monday announced it has signed a share purchase agreement to acquire 100% ownership of Zigi Carmel Initiatives & Investments for $28 million in stock.
    • MediWound Ltd. (NASDAQ:MDWD) dropped 18.2% to $1.43 after the company announced concurrent registered direct and private placement offerings priced at-the-market of roughly $30 million.
    • Schmitt Industries, Inc. (NASDAQ:SMIT) fell 18.2% to $2.57.
    • Motorsport Games Inc. (NASDAQ:MSGM) declined 16% to $0.70.
    • Luminar Technologies, Inc. (NASDAQ:LAZR) fell 16% to $7.89 after Northland Capital downgraded the stock from Outperform to Market Perform and lowered its price target from $13 to $10.
    • ECMOHO Limited (NASDAQ:MOHO) fell 15.8% to $0.1468 after jumping over 50% on Wednesday.
    • Nauticus Robotics, Inc. (NASDAQ:KITT) fell 15.3% to $5.39. Schlumberger B.V. recently disclosed 15.5% passive stake in Nauticus Robotics.
    • Cepton, Inc. (NASDAQ:CPTN) fell 15% to $1.74. Cepton recently announced a collaboration with NVIDIA to add Cepton lidar models into NVIDIA DRIVE Sim.
    • iHuman Inc. (NYSE:IH) dropped 15% to $1.69 following Q2 results.
    • AgriFORCE Growing Systems Ltd. (NASDAQ:AGRI) declined 14.6% to $1.5110. AgriFORCE announced purchase agreement with Stronghold Power Systems to acquire land for Coachella Campus.
    • Altamira Therapeutics Ltd. (NASDAQ:CYTO) fell 14.3% to $0.2706.
    • S&W Seed Company (NASDAQ:SANW) fell 14% to $0.7267.
    • Stitch Fix, Inc. (NASDAQ:SFIX) dropped 13.6% to $4.1895. Barclays maintained Stitch Fix with an Equal-Weight and lowered the price target from $7 to $5.
    • Jiuzi Holdings, Inc. (NASDAQ:JZXN) dropped 13% to $0.3580.
    • China Pharma Holdings, Inc. (NYSE:CPHI) shares fell 13% to $0.1343.
    • AMC Entertainment Holdings, Inc. (NYSE:APE) declined 11.4% to $3.5250.
    • DBV Technologies S.A. (NASDAQ:DBVT) dropped 11.3% to $1.96 after the company announced the FDA has placed a partial clinical hold on its VITESSE phase 3 clinical study.
    • Impinj, Inc. (NASDAQ:PI) fell 9% to $84.20.
    • Carvana Co. (NYSE:CVNA) fell 9% to $27.87.
    • Steakholder Foods Ltd. (NASDAQ:STKH) fell 8.7% to $2.31.
    • Avis Budget Group, Inc. (NASDAQ:CAR) dropped 7.7% to $138.81.
    • Novavax, Inc. (NASDAQ:NVAX) fell 7.5% to $23.93. JP Morgan downgraded Novavax from Neutral to Underweight and lowered the price target from $132 to $27.
    • Soluna Holdings, Inc. (NASDAQ:SLNH) fell 7.1% to $1.56 after gaining around 6% on Wednesday.
    • KB Home (NYSE:KBH) fell 4.6% to $26.72. KB Home reported better-than-expected earnings for its third quarter. The company also said it sees Q4 housing revenue of $1.95 billion to $2.05 billion.
    • Darden Restaurants, Inc. (NYSE:DRI) dropped 4.1% to $125.89 after the company reported worse-than-expected Q1 sales results.

     

    Get the next $AGRI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGRI
    $ALBO
    $AVCT
    $BCAN

    CompanyDatePrice TargetRatingAnalyst
    Li Auto Inc.
    $LI
    2/9/2026$14.00Neutral → Underweight
    Analyst
    Impinj Inc.
    $PI
    2/6/2026$112.00Outperform → In-line
    Evercore ISI
    Inventiva S.A.
    $IVA
    1/28/2026$18.00Overweight
    Barclays
    Li Auto Inc.
    $LI
    1/23/2026$17.50Buy → Hold
    Jefferies
    Darden Restaurants Inc.
    $DRI
    1/23/2026Hold → Buy
    Melius
    Darden Restaurants Inc.
    $DRI
    1/23/2026$235.00Neutral → Outperform
    Mizuho
    Darden Restaurants Inc.
    $DRI
    1/21/2026Outperform → Mkt Perform
    Raymond James
    Inventiva S.A.
    $IVA
    1/12/2026$12.00Outperform
    Leerink Partners
    More analyst ratings

    $AGRI
    $ALBO
    $AVCT
    $BCAN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    FDA Approval for NEXOBRID issued to MEDIWOUND, LTD

    Submission status for MEDIWOUND, LTD's drug NEXOBRID (SUPPL-10) with active ingredient ANACAULASE-BCDB has changed to 'Approval' on 08/15/2024. Application Category: BLA, Application Number: 761192, Application Classification:

    8/16/24 4:36:54 AM ET
    $MDWD
    Medicinal Chemicals and Botanical Products
    Health Care

    $AGRI
    $ALBO
    $AVCT
    $BCAN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

    CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company's biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. He currently serves as Co-Founder and CEO of Athos Therapeutics Inc., an AI software and clinical-stage biotechnology company focused on developing precision therapeutics for autoimmun

    2/24/26 12:30:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    KB HOME ANNOUNCES THE GRAND OPENING OF ITS THIRD NEW COMMUNITY WITHIN THE HIGHLY DESIRABLE COMPASS POINTE MASTER PLAN IN ONTARIO, CALIFORNIA

    Equinox at Compass Pointe offers personalized new townhomes with planned community amenities and walking distance to top-rated schools and parks, priced from the low $500,000s. ONTARIO, Calif., Feb. 23, 2026 /PRNewswire/ -- KB Home (NYSE:KBH), one of the largest and most trusted homebuilders in the U.S., today announced the grand opening of Equinox, its newest community within the highly desirable Compass Pointe master plan in Ontario, California. Situated in San Bernardino County, Ontario is an ideal blend of small-town charm, scenic views and a welcoming downtown district where residents and visitors can enjoy an array of cozy cafés, trendy restaurants, eclectic boutiques, artisan studios

    2/23/26 8:00:00 AM ET
    $KBH
    Homebuilding
    Consumer Discretionary

    TOP Ships Inc. Announces Agreement to Acquire Nine ECO MR Product Tanker Newbuildings with Time Charter Employment and Potential Gross Revenue Backlog of about $679 million

    ATHENS, Greece, Feb. 23, 2026 (GLOBE NEWSWIRE) -- TOP Ships Inc. (the "Company"), an international owner and operator of modern, fuel efficient "ECO" tanker vessels, announced today that it has entered into an agreement with an entity affiliated with the Company's Chief Executive Officer, ("the Seller"), to acquire 100% of the issued and outstanding shares of nine Marshall Islands companies (the "SPVs"), counterparties to ship building contracts for nine very-high specification 47,499 dwt Medium Range ("MR") product/chemical oil tankers with Guangzhou Shipyard International Company Limited, scheduled for delivery during 2028 and 2029. The ship building contracts' effectiveness is subject

    2/23/26 8:00:00 AM ET
    $TOPS
    Marine Transportation
    Consumer Discretionary

    $AGRI
    $ALBO
    $AVCT
    $BCAN
    SEC Filings

    View All

    SEC Form 20-F filed by Jiuzi Holdings Inc.

    20-F - Jiuzi Holdings, Inc. (0001816172) (Filer)

    2/24/26 4:13:43 PM ET
    $JZXN
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    SEC Form 6-K filed by TOP Ships Inc.

    6-K - TOP SHIPS INC. (0001296484) (Filer)

    2/23/26 8:00:22 AM ET
    $TOPS
    Marine Transportation
    Consumer Discretionary

    SEC Form 10-K filed by Virtu Financial Inc.

    10-K - Virtu Financial, Inc. (0001592386) (Filer)

    2/20/26 5:09:48 PM ET
    $VIRT
    Investment Bankers/Brokers/Service
    Finance

    $AGRI
    $ALBO
    $AVCT
    $BCAN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Li Auto downgraded by Analyst with a new price target

    Analyst downgraded Li Auto from Neutral to Underweight and set a new price target of $14.00

    2/9/26 7:00:29 AM ET
    $LI
    Auto Manufacturing
    Industrials

    Impinj downgraded by Evercore ISI with a new price target

    Evercore ISI downgraded Impinj from Outperform to In-line and set a new price target of $112.00

    2/6/26 8:09:28 AM ET
    $PI
    Industrial Machinery/Components
    Technology

    Barclays initiated coverage on Inventiva with a new price target

    Barclays initiated coverage of Inventiva with a rating of Overweight and set a new price target of $18.00

    1/28/26 7:17:30 AM ET
    $IVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGRI
    $ALBO
    $AVCT
    $BCAN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Pentwater Capital Management Lp bought $40,060,075 worth of shares (425,000 units at $94.26) and exercised 85,200 in-the-money shares at a strike of $130.46 (SEC Form 4)

    4 - AVIS BUDGET GROUP, INC. (0000723612) (Issuer)

    2/24/26 9:40:48 PM ET
    $CAR
    Rental/Leasing Companies
    Consumer Discretionary

    New insider Pentwater Capital Management Lp claimed ownership of 3,562,100 shares (SEC Form 3)

    3 - AVIS BUDGET GROUP, INC. (0000723612) (Issuer)

    2/24/26 9:37:08 PM ET
    $CAR
    Rental/Leasing Companies
    Consumer Discretionary

    Director Hees Bernardo was granted 2,592 shares (SEC Form 4)

    4 - AVIS BUDGET GROUP, INC. (0000723612) (Issuer)

    2/24/26 6:02:06 PM ET
    $CAR
    Rental/Leasing Companies
    Consumer Discretionary

    $AGRI
    $ALBO
    $AVCT
    $BCAN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Pentwater Capital Management Lp bought $40,060,075 worth of shares (425,000 units at $94.26) and exercised 85,200 in-the-money shares at a strike of $130.46 (SEC Form 4)

    4 - AVIS BUDGET GROUP, INC. (0000723612) (Issuer)

    2/24/26 9:40:48 PM ET
    $CAR
    Rental/Leasing Companies
    Consumer Discretionary

    Chief Executive Officer Siokas Grigorios bought $145,000 worth of shares (388,532 units at $0.37), increasing direct ownership by 5% to 8,861,914 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/13/26 10:05:37 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Siokas Grigorios bought $120,000 worth of shares (291,262 units at $0.41), increasing direct ownership by 4% to 8,473,382 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/12/26 2:20:08 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    $AGRI
    $ALBO
    $AVCT
    $BCAN
    Leadership Updates

    Live Leadership Updates

    View All

    Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

    CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company's biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. He currently serves as Co-Founder and CEO of Athos Therapeutics Inc., an AI software and clinical-stage biotechnology company focused on developing precision therapeutics for autoimmun

    2/24/26 12:30:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    KB HOME NAMES ROBERT MCGIBNEY CHIEF EXECUTIVE OFFICER

    Jeffrey Mezger Becomes Company's First Executive Chairman LOS ANGELES, Jan. 28, 2026 /PRNewswire/ -- KB Home (NYSE:KBH) today announced that, as part of its long-term succession planning process, its board of directors appointed Robert McGibney as President and Chief Executive Officer, effective March 1, 2026.  At that time, McGibney, a KB Home veteran with over 25 years of service, will succeed Jeffrey Mezger, who will become KB Home's first Executive Chairman of the board after serving as Chief Executive Officer for two decades and Chairman since 2016.  The board also appoi

    1/28/26 4:10:00 PM ET
    $KBH
    Homebuilding
    Consumer Discretionary

    HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer

    Brings more than 25 years of experience in building and scaling groundbreaking cardiovascular technologies Will initially focus on launching the Company's FDA-cleared 12-lead ECG system for arrhythmia assessment Will lead the Company's broader commercialization strategy across key growth initiatives, including heart attack detection and the 12-lead ECG extended-wear patch HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the appointment of Bryan Humbarger as Chief Commercial Officer, effective January 22, 2026. In this newly created role, Mr. Humbarger will lead commercial strate

    1/22/26 7:00:00 AM ET
    $BEAT
    Medical/Dental Instruments
    Health Care

    $AGRI
    $ALBO
    $AVCT
    $BCAN
    Financials

    Live finance-specific insights

    View All

    Darden Restaurants to Release Fiscal 2026 Third Quarter Results on March 19, 2026

    ORLANDO, Fla., Feb. 19, 2026 /PRNewswire/ -- Darden Restaurants, Inc. (NYSE:DRI) plans to release its fiscal 2026 third quarter financial results before the market opens on Thursday, March 19, 2026. The Company will host a conference call, led by Rick Cardenas, President and Chief Executive Officer, and Raj Vennam, Chief Financial Officer, to review third quarter results and conduct a question‑and‑answer session on Thursday, March 19, 2026, at 8:30 a.m. ET. The conference call will be webcast and can be accessed through the Company's Investor Relations website at investor.darden.com. Supplementary materials will be available on the website prior to the start of the conference call. A replay

    2/19/26 4:15:00 PM ET
    $DRI
    Restaurants
    Consumer Discretionary

    Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    GAITHERSBURG, Md., Feb. 19, 2026 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX) today announced it will report its fourth quarter and full year 2025 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Thursday, February 26, 2026. Details of the event and replay are as follows:Conference call details:Date:February 26, 2026Time:8:30 a.m. ETURL to register phone:Register HereDial-in number:(888) 880-3330 (U.S.) or(+1) (646) 357-8766 (International)Webcast:ir.novavax.com/eventsParticipants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back.Participants can als

    2/19/26 8:00:00 AM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Talkspace Announces Fourth Quarter and Full Year 2025 Results

    4Q 2025 total revenue grew 29% year-over-year to $63.0 million4Q 2025 net income of $4.8 million and adjusted EBITDA1 of $6.6 million Full-year 2025 total revenue grew 22% year-over-year to $228.9 millionFull-year 2025 net income of $7.8 millionFull-year 2025 adjusted EBITDA1 grew 127% year-over-year to $15.8 million  NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace" or the "Company") (NASDAQ:TALK), today reported fourth quarter and full year 2025 financial results.   Three Months EndedDecember 31, Year EndedDecember 31,   2025 2024 2025 2024   Results % Variancefrom PriorYear Results % Variancefrom PriorYear (In thousands unless otherwise noted)Unaudited Unaudited  

    2/19/26 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $AGRI
    $ALBO
    $AVCT
    $BCAN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by United Maritime Corporation

    SC 13D/A - United Maritime Corp (0001912847) (Subject)

    11/26/24 4:05:48 PM ET
    $USEA
    Marine Transportation
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by S&W Seed Company

    SC 13D/A - S&W Seed Co (0001477246) (Subject)

    11/20/24 7:34:11 PM ET
    $SANW
    Farming/Seeds/Milling
    Consumer Staples